VALANX Biotech wins “Most Promising Technology” at BioFIT 2021
We are proud to announce that we outdid over 70 competitors and were able to win the pitch competition in the category “Collaboration and Licensing opportunity”. A Thank you! to the jury and the organizers of BioFIT 2021, for giving us the opportunity to present our promising platform technology and to garner interest from potential customers and collaboration partners. Our technology has now been given the seal “Most Promising Technology” by a top-class jury consisting of experts in the biotech and pharma space. Click here if you want to find out how we can assist you in developing cutting-edge biologics and novel applications for site-directed protein conjugations.